Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

CAPS Rating: 2 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar 21popsontop (< 20) Submitted: 11/24/2010 5:39:07 AM : Outperform Start Price: $19.70 AUXL Score: -13.03

Drug dealers with a license.

Featured Broker Partners


Advertisement